• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Will Aducanumab get FDA approval June 7th?

Quote

Will Aducanumab be approved by FDA on June 7th?

  • No. The FDA sides with the Advisory Board, acknowledging significant lack of efficacy data

    Votes: 0 0.0%

  • Yes. The FDA is currently working on the label and REMS, which will be a very narrow indication

    Votes: 0 0.0%

  • Yes. Janet Woodcock will be acting commissioner for FDA and favors Biogen

    Votes: 0 0.0%

  • No. Joshua Sharfstein will be acting commissioner for FDA and vote no and request a second trial

    Votes: 0 0.0%
  • Total voters
    0
















anonymous said:
Uh. Hey Alisha, this what your reps and managers are doing all day. For months. This and posting self-development on linked-in.
Click to expand...
But some win p club, vp , diamond club for doing nothing. Eventually everyone at Biogen wins something. It is a joke! Don’t worry the bloat will be gone soon enough!
 








Top Bottom
Back
Quote